The JAK2V617F mutation can occur in a hematopoietic stem cell that exhibits no proliferative advantage: A case of human allogeneic transplantation

Blood

Volumn 112, Issue 3, 2008, Pages 921-922

  Van Pelt, Kristien ^b   Nollet, Friedel ^b   Selleslag, Dominik ^b   Knoops, Laurent ^b   Constantinescu, Stefan N ^b   Criel, Arnold ^b   Billiet, Johan ^a  

^a General Hospital St Jan   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

JANUS KINASE; JAK2 PROTEIN, HUMAN; JANUS KINASE 2;

ALLOGENEIC STEM CELL TRANSPLANTATION; ANAMNESIS; BLOOD EXAMINATION; CANCER CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CELL PROLIFERATION; FEMALE; GENE MUTATION; HEMATOPOIETIC STEM CELL; HLA MATCHING; HUMAN; LETTER; LEUKOCYTOSIS; MYELODYSPLASTIC SYNDROME; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; THROMBOCYTOSIS; ALLOTRANSPLANTATION; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MISSENSE MUTATION;

CELL PROLIFERATION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; JANUS KINASE 2; MUTATION, MISSENSE; MYELODYSPLASTIC SYNDROMES; TRANSPLANTATION, HOMOLOGOUS;

EID: 50949109491     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-04-154708     Document Type: Letter

References (7)

1. Baxter EJ, Scott LM, Campbell PJ, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005;365:1054-1061.
2. Campbell PJ, Green AR. The myeloproliferative disorders. N Engl J Med. 2006; 355:2452-2466.
3. James C, Ugo V, Le Gouedic JP, et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature. 2005:434:1144-1148.
4. Sidon P, Heimann P, Lambert F Dessars B, Robin V, El Housni H. Gombined locked nucleic acid and molecular beacon technologies for sensitive detection of the JAK2V617F somatic single-base sequence variant. Clin Chem. 2006;52:1436-1438.
5. James C, Delhommeau F, Marzac C, et al. Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis. Leukemia. 2006;20:350-353.
6. Kiladjian JJ. Cervantes F, Leebeek FW, et al. The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis. A report on 241 cases. Blood:Prepublished on Feb 4, 2008; as DOI:10.1182/blood-2007-2011- 125328.
7. Pardanani A, Fridley BL, Lasho TL, Gilliland DG, Tefferi A. Host genetic variation contributes to phenotypic diversity in myeloproliferative disorders. Blood. 2008;111:2785-2789.